Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SFDA Issues Revised GMP Draft Guideline Following Industry Comments; Expects Compliance To Come In Stages

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - Following industry comments, China's State FDA released another draft GMP guideline for which it seeks additional public comments. The revised draft offers clarity on a few key points but still leaves huge gaps that will need to be filled slowly over time

You may also be interested in...



Jordanian Drug Maker Buys Baxter Injectable Business, Becomes Second Largest In U.S.

Fast-growing Jordanian drug maker Hikma will acquire Baxter Healthcare's U.S. generic injectables business for $112 million. The acquisition doubles Hikma's injectables business and bolsters the company to the No. 2 position in the U.S. market with a projected market share of more than 15 percent. It also solidifies Hikma's leading position in the Middle East and North African (MENA) market, one of the rapidly growing "pharmerging" markets in the world

Jordanian Drug Maker Buys Baxter Injectable Business, Becomes Second Largest In U.S.

Fast-growing Jordanian drug maker Hikma will acquire Baxter Healthcare's U.S. generic injectables business for $112 million. The acquisition doubles Hikma's injectables business and bolsters the company to the No. 2 position in the U.S. market with a projected market share of more than 15 percent. It also solidifies Hikma's leading position in the Middle East and North African (MENA) market, one of the rapidly growing "pharmerging" markets in the world

Japan To Announce Medical Device Reimbursement Cuts In Coming Weeks

Companies selling medical devices in Japan will be notified in the next few weeks of payment rate reductions for their products following the recent release of reimbursement rules for the 2010-2012 cycle

Related Content

Latest News
See All
UsernamePublicRestriction

Register

SC070619

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel